Tag Archives: PRRT

10 Highlights for the Carcinoid and Neuroendocrine Tumor Community

PET/CT using Gallium-68 DOTATOC captures hidden source of neuroendocrine cancer. “An investigational molecular imaging technique could be the key to finding the elusive primary tumor, say presenters at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular … Continue reading

Posted in carcinoid cancer, neuroendocrine cancer, neuroendocrine tumors | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

DENIED: Michael Farris’ Journey with Insurance for Neuroendocrine Cancer Treatment

The good news is the very positive result at the end – but the road to getting insurance coverage for Michael Farris’ participation in the PRRT (peptide receptor radionuclide therapy) clinical trial at Excel Diagnostics in Houston, Texas, was fraught … Continue reading

Posted in carcinoid cancer, clinical trials, neuroendocrine cancer | Tagged , , , , , , , , , , , , , , , , , , , | 3 Comments

9 More News Items for the Carcinoid and Neuroendocrine Cancer Community

Carcinoid/neuroendocrine cancer specialist Dr. Eric Liu will be joining the Rocky Mountain Cancer Centers in Denver, Colorado, effective June 1, 2015. He and medical oncologist Dr. Allen Cohn, also from Rocky Mountain Cancer Centers, will head up a new Neuroendocrine … Continue reading

Posted in carcinoid, neuroendocrine cancer | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

3rd Theranostics World Congress Offers Free Patient Program on March 14

Johns Hopkins University in Baltimore, Maryland will be the site of the 3rd Theranostics World Congress on Ga-68 & PRRT from March 12-14, 2015. Co-sponsored by the Society of Nuclear Medicine and Molecular Imaging and Johns Hopkins Medicine, the Congress … Continue reading

Posted in carcinoid cancer, neuroendocrine tumors, nuclear imaging | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

First Northeastern Facility Offers Gallium-68 DOTATOC PET/CT Imaging for Carcinoid and Neuroendocrine Cancer Patients

When Brian Hakimian had the 68Gallium DOTATOC PET/CT scan at the Icahn School of Medicine, Mount Sinai in New York City on January 14, 2015, he became the first carcinoid patient to undergo this novel imaging test at a northeastern facility. … Continue reading

Posted in carcinoid, neuroendocrine cancer | Tagged , , , , , , , , , , , , , , , , , , , , , | 3 Comments

10 Highlights of the Year 2014 for the Carcinoid and Neuroendocrine Tumor Community

As the Carcinoid Cancer Foundation looks back on the year 2014, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past year. … Continue reading

Posted in carcinoid, neuroendocrine tumors | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 4 Comments

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging 2014 Meeting

Josh Mailman, President of the NorCal CarciNET Community  and Chair of the Patient Advocacy Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day on June 8th … Continue reading

Posted in neuroendocrine cancer awareness, neuroendocrine tumors, nuclear imaging, nuclear medicine tests | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment